Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Indene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 4/20 | 0.39 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.33 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indene SCHEMBL29746662 | 1.00 | CYP2D6 (0.51) | CYP2D6CYP2C19CA1CA2NOTUM | |
| Indene SCHEMBL27887053 | 0.98 | CYP2D6 (0.50) | CYP2D6CYP2C19CA1CA2NOTUM | |
| Indene SCHEMBL28769797 | 0.98 | CYP2D6 (0.50) | CYP2D6CYP2C19CA1CA2NOTUM | |
| Indene SCHEMBL28869263 | 0.94 | CYP2D6 (0.49) | CYP2D6CYP2C19CA1CA2NOTUM | |
| Indene SCHEMBL6700608 | 0.92 | CA2 (0.47) | CYP2D6CYP2C19CA1CA2NOTUM | |
| Indene SCHEMBL30959780 | 0.92 | CA2 (0.47) | CYP2D6CYP2C19CA1CA2NOTUM | |
| Indene SCHEMBL2769732 | 0.89 | CYP2D6 (0.53) | CYP2D6CYP2C19CA1CA2NOTUM | |
| Indene SCHEMBL5689989 | 0.89 | CYP2D6 (0.53) | CYP2D6CYP2C19CA1CA2HSD17B3 | |
| Indene SCHEMBL28216169 | 0.87 | CA1 (0.50) | CYP2D6CYP2C19CA1CA2NOTUM | |
| Indene SCHEMBL27563612 | 0.87 | CA1 (0.53) | CYP2D6CYP2C19CA1CA2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4111 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216311-A1 | FULLY-DILUTABLE, SELF-MICROEMULSIFYING DELIVERY SYSTEMS (SMEDDS) FOR POORLY WATER-SOLUBLE POLAR SOLUTES | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-07-04 | — | — | US | claimed |
| WO-2024044849-A1 | DILUTABLE COMPOSITIONS AND PROCESSES FOR EXTRACTING AND REFINING POORLY WATER-SOLUBLE POLAR OILS FROM BIOMASS | MICELLAE DELIVERY SYSTEMS INC. (CA) | 2024-03-07 | — | — | WO | claimed |
| US-20230405003-A1 | APPLICATION OF THYMIDINE DERIVATIVE IN PREPARATION OF DRUGS | ONQUALITY PHARMACEUTICALS CHINA LTD. (CN) | 2023-12-21 | — | — | US | claimed |
| EP-4271414-A1 | FULLY-DILUTABLE, SELF-MICROEMULSIFYING DELIVERY SYSTEMS (SMEDDS) FOR POORLY WATER-SOLUBLE POLAR SOLUTES | The Governing Council of the University of Toronto (CA) | 2023-11-08 | — | — | EP | claimed |
| EP-4238571-A1 | APPLICATION OF THYMIDINE DERIVATIVE IN PREPARATION OF DRUGS | OnQuality Pharmaceuticals China Ltd. (CN) | 2023-09-06 | — | — | EP | claimed |
| WO-2022140843-A1 | FULLY-DILUTABLE, SELF-MICROEMULSIFYING DELIVERY SYSTEMS (SMEDDS) FOR POORLY WATER-SOLUBLE POLAR SOLUTES | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2022-07-07 | — | — | WO | claimed |
| EP-3512503-A1 | LIPOSOMAL FORMULATIONS | Nanyang Technological University (SG) | 2019-07-24 | — | — | EP | claimed |
| US-20190216735-A1 | LIPOSOMAL FORMULATIONS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2019-07-18 | — | — | US | claimed |
| US-10076641-B2 | Methods and systems for delivering substances into luminal walls | THE SPECTRANETICS CORPORATION (US) | 2018-09-18 | — | — | US | claimed |
| WO-2018052373-A1 | LIPOSOMAL FORMULATIONS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2018-03-22 | — | — | WO | claimed |
| EP-1592386-A2 | COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS | Elan Pharmaceuticals, Inc. (US) | 2005-11-09 | — | — | EP | claimed |
| EP-1592387-A2 | COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS | Elan Pharmaceuticals, Inc. (US) | 2005-11-09 | — | — | EP | claimed |
| US-20050215565-A1 | Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents | BIOGEN MA INC. | 2005-09-29 | — | — | US | claimed |
| US-20050069541-A1 | Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents | BIOGEN IDEC INTERNATIONAL HOLDING LTD. (BM) | 2005-03-31 | — | — | US | claimed |
| WO-2004066932-A2 | COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS | ELAN PHARMACEUTICALS INC. (US) | 2004-08-12 | — | — | WO | claimed |
| WO-2004066931-A2 | COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS | ELAN PHARMACEUTICALS INC. (US) | 2004-08-12 | — | — | WO | claimed |
| US-20030212123-A1 | COX-2 selective carprofen for treating pain and inflammation in dogs | PFIZER INC. | 2003-11-13 | — | — | US | claimed |
| US-20030176421-A1 | PROKINETIC AGENTS FOR TREATING GASTRIC HYPOMOTILITY AND RELATED DISORDERS | WATSON JOHN W (US) | 2003-09-18 | — | — | US | claimed |
| EP-0642336-A1 | USE OF NSIAD IN THE TREATMENT OF DEMENTIA | UNIVERSITY OF BRITISH COLUMBIA (CA) | 1995-03-15 | — | — | EP | claimed |
| WO-1993024115-A1 | ANTI-RHEUMATOID ARTHRITIC DRUGS IN THE TREATMENT OF DEMENTIA | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1993-12-09 | — | — | WO | claimed |